Cost-Efficiency in Healthcare: Germany Generic Injectables Market...

ha aggiunto una foto Health

2025-12-23 08:55:29 -

Cost-Efficiency in Healthcare: Germany Generic Injectables Market Set for 6.2% Growth as Biologics Face Patent Cliffs

Germany's pharmaceutical sector is undergoing a structural shift toward cost-containment, placing the generic injectables market in a prime position for growth. As several high-cost biologic drugs face patent expirations over the next five years, the German healthcare system is actively encouraging the switch to more affordable generic and biosimilar alternatives. This is particularly evident...

0 Commenti 0 condivisioni 51 Views 0 Anteprima